Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer.
about
Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and InflammationThe inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells.IKK is a therapeutic target in KRAS-Induced lung cancer with disrupted p53 activity.Promotion of lung tumor growth by interleukin-17Differential expression of IL-17, 22 and 23 in the progression of colorectal cancer in patients with K-ras mutation: Ras signal inhibition and crosstalk with GM-CSF and IFN-γThe association between expressions of Ras and CD68 in the angiogenesis of breast cancers.Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesisOncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.Defining the molecular signature of chemotherapy-mediated lung tumor phenotype modulation and increased susceptibility to T-cell killing.Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expressionPositive feedback regulation between IL10 and EGFR promotes lung cancer formation.Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells.Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma.KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach.MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer.Interleukin-1α is the major alarmin of lung epithelial cells released during photodynamic therapy to induce inflammatory mediators in fibroblasts.Significant association between IL-32 gene polymorphisms and susceptibility to endometrial cancer in Chinese Han women.NF-kappaB in lung tumorigenesis.Disseminated lung cancer presenting as a rectal mass.Metformin Suppressed CXCL8 Expression and Cell Migration in HEK293/TLR4 Cell Line.Myc Cooperates with Ras by Programming Inflammation and Immune Suppression.Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer.Integrin αvβ6 Promotes Lung Cancer Proliferation and Metastasis through Upregulation of IL-8-Mediated MAPK/ERK Signaling.
P2860
Q26796395-278ACE8B-61E2-4817-9B96-7A7568247895Q33587770-86F969AF-A341-475C-9ACA-C9BAA4C5E5A5Q33776852-FA009054-CCF3-4AB2-8D29-0EE9C1BD2F27Q34201267-3936D9ED-F775-4505-9B7B-3EE4D0058CEDQ34989005-1512F245-32BC-4782-A06B-68D49230AD31Q35079068-CB9B412D-7AE5-4C45-9978-50A76699C223Q35196919-389CE923-AE47-40FA-B606-7B1FA42E502CQ35671281-B37FBC81-CE23-47A3-AFF5-C1F4060D9736Q35752182-32D83443-0ED4-4F84-BEC6-ABD6EFB3681CQ36093867-1F6F9E22-1968-4B2C-9664-D8723DAF2955Q36322948-2C13E3AB-2339-4703-BE01-85F3FEB3C8ADQ37190457-B99BE5AA-5930-48BC-BB8F-A71DC3EDB2CAQ37211974-8925424F-5701-4C73-859E-96E2ED7C813CQ37711636-4201D295-8B02-48AE-A924-7F7EFC688A0EQ38390027-34FE2A71-8A6D-443D-B9F7-499D196BC6C2Q41008660-A89E4F89-E381-4419-9136-309A39A73444Q41319934-4898B8E3-F6D0-41CC-AFBE-CAEA3EE152E7Q41495034-0C036D0B-25AB-4FE8-89AA-74AE220F98AAQ42213074-C32EDBC8-C217-4358-B4C0-B5129A72F2C9Q42390049-986DDB75-7ACC-4B9A-B074-6835116A98C6Q44630049-1DC4FBDE-FDE1-4A46-BC64-666C78872B98Q46758501-BF216CF0-0E56-4EDB-9BF1-7E83814B106BQ53404199-D1ABECCF-82D1-486A-974B-F1757F445ECBQ55380671-5348FDEE-1AF7-4C6A-9878-E22E2DBFD095
P2860
Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Oncogenic KRAS-induced interle ...... of non-small cell lung cancer.
@ast
Oncogenic KRAS-induced interle ...... of non-small cell lung cancer.
@en
type
label
Oncogenic KRAS-induced interle ...... of non-small cell lung cancer.
@ast
Oncogenic KRAS-induced interle ...... of non-small cell lung cancer.
@en
prefLabel
Oncogenic KRAS-induced interle ...... of non-small cell lung cancer.
@ast
Oncogenic KRAS-induced interle ...... of non-small cell lung cancer.
@en
P2093
P2860
P356
P1476
Oncogenic KRAS-induced interle ...... of non-small cell lung cancer.
@en
P2093
Adi F Gazdar
David S Shames
Hisao Imai
John D Minna
Kimihiro Shimizu
Kyoichi Kaira
Luc Girard
Masatomo Mori
Mitsuo Sato
Noriaki Sunaga
P2860
P304
P356
10.1002/IJC.26164
P577
2011-08-03T00:00:00Z